AKT1 and neoplasm: Futhermore, in our study ERK inhibition exhibited much weaker anti-tumor effect than AKT inhibition in general, which could be attributed to feedback activation of p-AKT induced by ERK inhibitor PD98059 in shDsg2 and shDsc2 MDA-MB-231 cells.